NYSE:HQL

Tekla Life Sciences Investors Competitors

$19.71
+0.17 (+0.87 %)
(As of 04/14/2021 04:15 PM ET)
Add
Compare
Today's Range
$19.64
Now: $19.71
$20.02
50-Day Range
$19.28
MA: $20.19
$21.81
52-Week Range
$15.79
Now: $19.71
$22.32
Volume84,033 shs
Average Volume85,910 shs
Market Capitalization$448.60 million
P/E RatioN/A
Dividend Yield8.09%
Beta1.09

Competitors

Tekla Life Sciences Investors (NYSE:HQL) Vs. USA, USA, TYG, BIF, QQQX, and AWF

Should you be buying HQL stock or one of its competitors? Companies in the industry of "investment offices, not elsewhere classified" are considered alternatives and competitors to Tekla Life Sciences Investors, including Liberty All-Star Equity Fund (USA), Liberty All-Star Equity Fund (USA), Tortoise Energy Infrastructure (TYG), Boulder Growth & Income Fund (BIF), Nuveen Nasdaq 100 Dynamic Overwrite Fund (QQQX), and AllianceBernstein Global High Income Fund (AWF).

Liberty All-Star Equity Fund (NYSE:USA) and Tekla Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, dividends, analyst recommendations, profitability, earnings and valuation.

Dividends

Liberty All-Star Equity Fund pays an annual dividend of $0.65 per share and has a dividend yield of 7.9%. Tekla Life Sciences Investors pays an annual dividend of $1.58 per share and has a dividend yield of 8.0%. Liberty All-Star Equity Fund has increased its dividend for 1 consecutive years and Tekla Life Sciences Investors has increased its dividend for 1 consecutive years.

Profitability

This table compares Liberty All-Star Equity Fund and Tekla Life Sciences Investors' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Liberty All-Star Equity FundN/AN/AN/A
Tekla Life Sciences InvestorsN/AN/AN/A

Risk and Volatility

Liberty All-Star Equity Fund has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500. Comparatively, Tekla Life Sciences Investors has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Liberty All-Star Equity Fund and Tekla Life Sciences Investors, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Liberty All-Star Equity Fund00103.00
Tekla Life Sciences Investors0000N/A

Liberty All-Star Equity Fund currently has a consensus target price of $5.70, suggesting a potential downside of 30.83%. Given Liberty All-Star Equity Fund's higher possible upside, analysts plainly believe Liberty All-Star Equity Fund is more favorable than Tekla Life Sciences Investors.

Earnings and Valuation

This table compares Liberty All-Star Equity Fund and Tekla Life Sciences Investors' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Liberty All-Star Equity FundN/AN/AN/AN/AN/A
Tekla Life Sciences InvestorsN/AN/AN/AN/AN/A

Institutional & Insider Ownership

11.3% of Liberty All-Star Equity Fund shares are owned by institutional investors. Comparatively, 18.1% of Tekla Life Sciences Investors shares are owned by institutional investors. 0.1% of Liberty All-Star Equity Fund shares are owned by insiders. Comparatively, 10.1% of Tekla Life Sciences Investors shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Tekla Life Sciences Investors (NYSE:HQL) and Liberty All-Star Equity Fund (NYSE:USA) are both small-cap finance companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, valuation, profitability and institutional ownership.

Profitability

This table compares Tekla Life Sciences Investors and Liberty All-Star Equity Fund's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tekla Life Sciences InvestorsN/AN/AN/A
Liberty All-Star Equity FundN/AN/AN/A

Analyst Ratings

This is a summary of recent ratings and target prices for Tekla Life Sciences Investors and Liberty All-Star Equity Fund, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tekla Life Sciences Investors0000N/A
Liberty All-Star Equity Fund00103.00

Liberty All-Star Equity Fund has a consensus target price of $5.70, indicating a potential downside of 30.83%. Given Liberty All-Star Equity Fund's higher possible upside, analysts plainly believe Liberty All-Star Equity Fund is more favorable than Tekla Life Sciences Investors.

Institutional and Insider Ownership

18.1% of Tekla Life Sciences Investors shares are held by institutional investors. Comparatively, 11.3% of Liberty All-Star Equity Fund shares are held by institutional investors. 10.1% of Tekla Life Sciences Investors shares are held by company insiders. Comparatively, 0.1% of Liberty All-Star Equity Fund shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Tekla Life Sciences Investors and Liberty All-Star Equity Fund's gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tekla Life Sciences InvestorsN/AN/AN/AN/AN/A
Liberty All-Star Equity FundN/AN/AN/AN/AN/A

Dividends

Tekla Life Sciences Investors pays an annual dividend of $1.58 per share and has a dividend yield of 8.0%. Liberty All-Star Equity Fund pays an annual dividend of $0.65 per share and has a dividend yield of 7.9%. Tekla Life Sciences Investors has increased its dividend for 1 consecutive years and Liberty All-Star Equity Fund has increased its dividend for 1 consecutive years.

Volatility and Risk

Tekla Life Sciences Investors has a beta of 1.09, indicating that its stock price is 9% more volatile than the S&P 500. Comparatively, Liberty All-Star Equity Fund has a beta of 1.26, indicating that its stock price is 26% more volatile than the S&P 500.

Tekla Life Sciences Investors (NYSE:HQL) and Tortoise Energy Infrastructure (NYSE:TYG) are both small-cap finance companies, but which is the superior stock? We will compare the two businesses based on the strength of their risk, earnings, profitability, institutional ownership, dividends, analyst recommendations and valuation.

Analyst Recommendations

This is a summary of recent recommendations for Tekla Life Sciences Investors and Tortoise Energy Infrastructure, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tekla Life Sciences Investors0000N/A
Tortoise Energy Infrastructure01002.00

Profitability

This table compares Tekla Life Sciences Investors and Tortoise Energy Infrastructure's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tekla Life Sciences InvestorsN/AN/AN/A
Tortoise Energy InfrastructureN/AN/AN/A

Insider and Institutional Ownership

18.1% of Tekla Life Sciences Investors shares are held by institutional investors. Comparatively, 5.7% of Tortoise Energy Infrastructure shares are held by institutional investors. 10.1% of Tekla Life Sciences Investors shares are held by insiders. Comparatively, 0.2% of Tortoise Energy Infrastructure shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Dividends

Tekla Life Sciences Investors pays an annual dividend of $1.58 per share and has a dividend yield of 8.0%. Tortoise Energy Infrastructure pays an annual dividend of $0.92 per share and has a dividend yield of 3.6%. Tekla Life Sciences Investors has raised its dividend for 1 consecutive years. Tekla Life Sciences Investors is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Valuation & Earnings

This table compares Tekla Life Sciences Investors and Tortoise Energy Infrastructure's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tekla Life Sciences InvestorsN/AN/AN/AN/AN/A
Tortoise Energy InfrastructureN/AN/AN/AN/AN/A

Volatility & Risk

Tekla Life Sciences Investors has a beta of 1.09, meaning that its stock price is 9% more volatile than the S&P 500. Comparatively, Tortoise Energy Infrastructure has a beta of 2.87, meaning that its stock price is 187% more volatile than the S&P 500.

Summary

Tekla Life Sciences Investors beats Tortoise Energy Infrastructure on 4 of the 5 factors compared between the two stocks.

Boulder Growth & Income Fund (NYSE:BIF) and Tekla Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, analyst recommendations and risk.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Boulder Growth & Income Fund and Tekla Life Sciences Investors, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Boulder Growth & Income Fund0000N/A
Tekla Life Sciences Investors0000N/A

Volatility & Risk

Boulder Growth & Income Fund has a beta of 0.9, indicating that its share price is 10% less volatile than the S&P 500. Comparatively, Tekla Life Sciences Investors has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500.

Dividends

Boulder Growth & Income Fund pays an annual dividend of $0.41 per share and has a dividend yield of 3.1%. Tekla Life Sciences Investors pays an annual dividend of $1.58 per share and has a dividend yield of 8.0%. Boulder Growth & Income Fund has raised its dividend for 1 consecutive years and Tekla Life Sciences Investors has raised its dividend for 1 consecutive years.

Institutional & Insider Ownership

12.1% of Boulder Growth & Income Fund shares are owned by institutional investors. Comparatively, 18.1% of Tekla Life Sciences Investors shares are owned by institutional investors. 0.2% of Boulder Growth & Income Fund shares are owned by company insiders. Comparatively, 10.1% of Tekla Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Earnings & Valuation

This table compares Boulder Growth & Income Fund and Tekla Life Sciences Investors' revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Boulder Growth & Income FundN/AN/AN/AN/AN/A
Tekla Life Sciences InvestorsN/AN/AN/AN/AN/A

Profitability

This table compares Boulder Growth & Income Fund and Tekla Life Sciences Investors' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Boulder Growth & Income FundN/AN/AN/A
Tekla Life Sciences InvestorsN/AN/AN/A

Summary

Tekla Life Sciences Investors beats Boulder Growth & Income Fund on 4 of the 4 factors compared between the two stocks.

Tekla Life Sciences Investors (NYSE:HQL) and Nuveen Nasdaq 100 Dynamic Overwrite Fund (NASDAQ:QQQX) are both small-cap finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, analyst recommendations, institutional ownership, profitability and dividends.

Analyst Ratings

This is a summary of current recommendations and price targets for Tekla Life Sciences Investors and Nuveen Nasdaq 100 Dynamic Overwrite Fund, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Tekla Life Sciences Investors0000N/A
Nuveen Nasdaq 100 Dynamic Overwrite Fund0000N/A

Dividends

Tekla Life Sciences Investors pays an annual dividend of $1.58 per share and has a dividend yield of 8.0%. Nuveen Nasdaq 100 Dynamic Overwrite Fund pays an annual dividend of $1.62 per share and has a dividend yield of 5.8%. Tekla Life Sciences Investors has increased its dividend for 1 consecutive years. Tekla Life Sciences Investors is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Insider & Institutional Ownership

18.1% of Tekla Life Sciences Investors shares are owned by institutional investors. Comparatively, 19.7% of Nuveen Nasdaq 100 Dynamic Overwrite Fund shares are owned by institutional investors. 10.1% of Tekla Life Sciences Investors shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Profitability

This table compares Tekla Life Sciences Investors and Nuveen Nasdaq 100 Dynamic Overwrite Fund's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Tekla Life Sciences InvestorsN/AN/AN/A
Nuveen Nasdaq 100 Dynamic Overwrite FundN/AN/AN/A

Valuation & Earnings

This table compares Tekla Life Sciences Investors and Nuveen Nasdaq 100 Dynamic Overwrite Fund's gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Tekla Life Sciences InvestorsN/AN/AN/AN/AN/A
Nuveen Nasdaq 100 Dynamic Overwrite FundN/AN/AN/AN/AN/A

Volatility and Risk

Tekla Life Sciences Investors has a beta of 1.09, suggesting that its stock price is 9% more volatile than the S&P 500. Comparatively, Nuveen Nasdaq 100 Dynamic Overwrite Fund has a beta of 1.14, suggesting that its stock price is 14% more volatile than the S&P 500.

Summary

Tekla Life Sciences Investors beats Nuveen Nasdaq 100 Dynamic Overwrite Fund on 3 of the 5 factors compared between the two stocks.

AllianceBernstein Global High Income Fund (NYSE:AWF) and Tekla Life Sciences Investors (NYSE:HQL) are both small-cap finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, earnings, institutional ownership, risk, analyst recommendations and profitability.

Volatility & Risk

AllianceBernstein Global High Income Fund has a beta of 0.69, meaning that its share price is 31% less volatile than the S&P 500. Comparatively, Tekla Life Sciences Investors has a beta of 1.09, meaning that its share price is 9% more volatile than the S&P 500.

Earnings & Valuation

This table compares AllianceBernstein Global High Income Fund and Tekla Life Sciences Investors' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
AllianceBernstein Global High Income FundN/AN/AN/AN/AN/A
Tekla Life Sciences InvestorsN/AN/AN/AN/AN/A

Institutional and Insider Ownership

18.1% of Tekla Life Sciences Investors shares are held by institutional investors. 1.0% of AllianceBernstein Global High Income Fund shares are held by company insiders. Comparatively, 10.1% of Tekla Life Sciences Investors shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Analyst Ratings

This is a breakdown of recent ratings and target prices for AllianceBernstein Global High Income Fund and Tekla Life Sciences Investors, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
AllianceBernstein Global High Income Fund0000N/A
Tekla Life Sciences Investors0000N/A

Dividends

AllianceBernstein Global High Income Fund pays an annual dividend of $0.79 per share and has a dividend yield of 6.6%. Tekla Life Sciences Investors pays an annual dividend of $1.58 per share and has a dividend yield of 8.0%. AllianceBernstein Global High Income Fund has increased its dividend for 1 consecutive years and Tekla Life Sciences Investors has increased its dividend for 1 consecutive years.

Profitability

This table compares AllianceBernstein Global High Income Fund and Tekla Life Sciences Investors' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
AllianceBernstein Global High Income FundN/AN/AN/A
Tekla Life Sciences InvestorsN/AN/AN/A

Summary

Tekla Life Sciences Investors beats AllianceBernstein Global High Income Fund on 4 of the 4 factors compared between the two stocks.


Tekla Life Sciences Investors Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Liberty All-Star Equity Fund logo
USA
Liberty All-Star Equity Fund
1.2$8.24+0.2%$1.75 billionN/A0.00Dividend Increase
Decrease in Short Interest
News Coverage
Liberty All-Star Equity Fund logo
USA
Liberty All-Star Equity Fund
0.9$8.24+0.2%$1.75 billionN/A0.00Dividend Increase
Decrease in Short Interest
News Coverage
Tortoise Energy Infrastructure logo
TYG
Tortoise Energy Infrastructure
0.7$25.60+2.4%$1.34 billionN/A0.00Increase in Short Interest
News Coverage
BIF
Boulder Growth & Income Fund
0.8$13.15+0.1%$1.29 billionN/A0.00
QQQX
Nuveen Nasdaq 100 Dynamic Overwrite Fund
0.3$28.13+1.0%$1.18 billionN/A0.00Decrease in Short Interest
News Coverage
AWF
AllianceBernstein Global High Income Fund
0.8$11.96+0.0%$1.03 billionN/A0.00Decrease in Short Interest
HQH
Tekla Healthcare Investors
0.8$24.34+0.7%$1.02 billionN/A0.00Increase in Short Interest
News Coverage
GAM
General American Investors
0.8$41.56+0.0%$1.02 billionN/A0.00Decrease in Short Interest
News Coverage
MYI
BlackRock MuniYield Quality Fund III
0.8$14.34+0.2%$979.32 millionN/A0.00Increase in Short Interest
Apollo Investment logo
AINV
Apollo Investment
1.2$14.17+0.1%$924.72 million$276.92 million-8.54Decrease in Short Interest
VMO
Invesco Municipal Opportunity Trust
0.9$13.43+0.7%$905.32 millionN/A0.00Decrease in Short Interest
PHK
PIMCO High Income Fund
0.9$6.81+0.6%$894.41 millionN/A0.00
SLR Investment logo
SLRC
SLR Investment
1.9$18.81+1.3%$794.91 million$154.71 million-156.75
TDF
Templeton Dragon Fund
1.0$22.45+0.1%$757.89 millionN/A0.00Increase in Short Interest
News Coverage
VGM
Invesco Trust for Investment Grade Municipals
1.0$13.73+0.1%$744.51 millionN/A0.00Decrease in Short Interest
VKQ
Invesco Municipal Trust
0.8$13.30+0.5%$735.76 millionN/A0.00Increase in Short Interest
BTO
John Hancock Financial Opportunities Fund
1.2$39.47+0.8%$734.10 millionN/A0.00Increase in Short Interest
GIM
Templeton Global Income Fund
1.1$5.39+0.0%$723.04 millionN/A0.00News Coverage
MYD
BlackRock MuniYield Fund
0.9$14.73+0.1%$691.13 millionN/A0.00Decrease in Short Interest
Invesco California Value Municipal Income Trust logo
VCV
Invesco California Value Municipal Income Trust
0.8$13.14+0.7%$629.01 millionN/A0.00Decrease in Short Interest
News Coverage
MUC
BlackRock MuniHoldings California Quality Fund
0.3$15.08+0.1%$618.31 millionN/A0.00
MVF
BlackRock MuniVest Fund
0.3$9.42+0.3%$610.79 millionN/A0.00Decrease in Short Interest
News Coverage
MMU
Western Asset Managed Municipals Fund
0.9$13.25+0.4%$572.46 millionN/A0.00Decrease in Short Interest
IFN
The India Fund
0.8$20.96+0.2%$564.03 millionN/A0.00Decrease in Short Interest
MFL
BlackRock MuniHoldings Investment Quality Fund
0.7$14.69+1.3%$556.69 millionN/A0.00Decrease in Short Interest
MUA
BlackRock MuniAssets Fund
0.9$15.19+1.1%$551.47 millionN/A0.00Increase in Short Interest
EVN
Eaton Vance Municipal Income Trust
0.8$13.78+0.2%$546.41 millionN/A0.00Increase in Short Interest
News Coverage
BlackRock MuniYield New York Quality Fund logo
MYN
BlackRock MuniYield New York Quality Fund
0.9$13.68+0.5%$538.78 millionN/A0.00Decrease in Short Interest
NQP
Nuveen Pennsylvania Quality Municipal Income Fund
0.8$14.41+0.4%$538.69 millionN/A0.00Decrease in Short Interest
LEO
BNY Mellon Strategic Municipals
0.7$8.65+0.7%$538.03 millionN/A0.00Increase in Short Interest
DSU
BlackRock Debt Strategies Fund
0.8$11.11+0.6%$520.15 millionN/A0.00Increase in Short Interest
News Coverage
MCA
BlackRock MuniYield California Quality Fund
0.8$14.96+0.2%$515.75 millionN/A0.00Decrease in Short Interest
News Coverage
BBH
VanEck Vectors Biotech ETF
0.5$180.28+0.9%$508.75 millionN/A0.00News Coverage
RMT
Royce Micro-Cap Trust
1.2$11.77+0.4%$507.28 millionN/A0.00Increase in Short Interest
News Coverage
DSM
BNY Mellon Strategic Municipal Bond Fund
0.9$8.04+0.4%$500.17 millionN/A0.00Increase in Short Interest
MQY
BlackRock MuniYield Quality Fund
0.8$16.11+0.3%$494.82 millionN/A0.00
PPT
Putnam Premier Income Trust
0.8$4.74+0.2%$489.26 millionN/A0.00
PMO
Putnam Municipal Opportunities Trust
0.8$13.88+1.1%$473.45 millionN/A0.00
KTF
DWS Municipal Income Trust
0.8$11.87+0.0%$468.88 millionN/A0.00Dividend Announcement
Decrease in Short Interest
MUJ
BlackRock MuniHoldings New Jersey Quality Fund
0.8$15.13+0.3%$455.22 millionN/A0.00
MIY
BlackRock MuniYield Michigan Quality Fund
0.9$15.21+0.4%$448.88 millionN/A0.00
MHN
BlackRock MuniHoldings New York Quality Fund
0.8$14.32+0.6%$445.81 millionN/A0.00Decrease in Short Interest
News Coverage
ZTR
Virtus Total Return Fund
0.8$9.35+0.1%$442.97 millionN/A0.00
MIN
MFS Intermediate Income Trust
1.0$3.66+0.3%$424.31 millionN/A0.00Decrease in Short Interest
PMM
Putnam Managed Municipal Income Trust
0.8$8.50+0.1%$415.48 millionN/A0.00News Coverage
ASA
ASA Gold and Precious Metals
0.9$21.00+0.8%$405.09 millionN/A0.00Increase in Short Interest
MFS Multimarket Income Trust logo
MMT
MFS Multimarket Income Trust
1.2$6.42+0.5%$393.77 millionN/A0.00
RFI
Cohen & Steers Total Return Realty Fund
1.0$14.93+0.8%$391.93 millionN/A0.00Decrease in Short Interest
News Coverage
BKT
BlackRock Income Trust
0.8$6.10+0.0%$389.16 millionN/A0.00Decrease in Short Interest
News Coverage
SOR
Source Capital
1.1$44.33+0.2%$371.84 millionN/A0.00Decrease in Short Interest
This page was last updated on 4/14/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.